Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07515482

Manual Acupuncture for Acute Primary Tinnitus

This clinical trial aims to assess the efficacy of manual acupuncture for patients with acute primary tinnitus.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,

Wuhan, Hubei, 430030, China

About this study

This is a multicentre, randomised, controlled clinical trial with blinded participants, outcome assessment and statistician. The total trial period will be 14 weeks, including two weeks of baseline assessment, four weeks of treatment, and eight weeks of follow-up. A total of 180 patients with acute primary tinnitus will be randomized in a 1:1:1 ratio to receive 10 sessions of manual acupuncture, 10 sessions of sham acupuncture, or usual care alone over 4 weeks. Informed consent will be obtained from each patient before randomization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18-65 years, male or female;
  • Primary complaint is persistent tinnitus (unilateral or bilateral);
  • Meet the diagnostic criteria for primary tinnitus according to the 2014 Clinical Practice Guideline developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF);
  • Had continuous tinnitus ≥2 weeks and <6 months;
  • Tinnitus should be bothersome, with a screening THI score 28-76;
  • Acupuncture naive;
  • Able to provide written informed consent.

Exclusion criteria

  • Objective tinnitus;
  • Pulsatile tinnitus;
  • Diagnosed as secondary tinnitus as evaluated by audiologists and clinicians(Menière's disease, temporomandibular joint disorder or other diseases);
  • Had evidence of conductive hearing loss (confirmed by abnormal otoscopy or tympanogram);
  • Had contraindications for acupuncture, including curent pregnant, severe anemia, coagulation disorders, etc;
  • Having difficulties in expressing their symptoms clearly( severe mental disorders or cognitive impairment);
  • Currently suffering from other serious acute or chronic organic diseases, such as cerebrovascular, cardiovascular, liver, kidney, hematological diseases, infectious diseases, or malignant tumors;
  • Has received intratympanic injection, postauricular injection, corticosteroids, or other medications for tinnitus treatment (includingTraditional Chinese Medicine or proprietary Chinese medicines) within the past 2 weeks or at baseline;
  • Participated in other clinical trials, particularly those closely related to tinnitus treatment, such as sound therapy;
  • have a strong desire for medication treatment.

Treatment and study plan

Manual acupuncture

Other

Ten manual acupuncture sessions will be delivered over 4 weeks, with treatment frequency decreasing from 3 sessions per week for the first 2 weeks to 2 sessions per week for the remaining weeks.

Sham Acupuncture

Other

Ten manual acupuncture sessions will be delivered over 4 weeks, with treatment frequency decreasing from 3 sessions per week for the first 2 weeks to 2 sessions per week for the last 2 weeks.

Usaual care

Behavioral

Health education and standard evaluation related to tinnitus

Primary outcomes

  1. Tinnitus Handicap Inventory (THI, 0-100)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    25-item measure of tinnitus-related handicap; total score 0-100, higher scores indicate greater handicap. In details, 0-16 points indicate no handicap; 18-36 points indicate mild handicap;38-56 points indicate moderate handicap; 58-76 points indicate severe handicap and >76 points indicate catastrophic handicap.

  2. Tinnitus Functional Index (TFI, 0-100)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    25-item self-report measure of tinnitus-related functional impact; total score 0-100, higher scores indicate greater impairment.

Secondary outcomes

  1. Effective response rate of THI

    Time frame: End of treatment at 4 weeks after randomization, 8 weeks after randomization and 12 weeks after randomization.

    Effective response rate of THI is defined as the proportion of patients with a THI score decrease of ≥7 points.

  2. Effective response rate of TFI.

    Time frame: End of treatment at 4 weeks after randomization, 8 weeks after randomization and 12 weeks after randomization.

    Effective response rate of TFI is defined as the proportion of patients with a TFI score decrease of ≥13 points.

  3. Visual Analogue Scale (VAS) for aural fullness

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    We will use a 10-mm Visual Analogue Scale (VAS) (0 = no tinnitus, 10 = the most loud of tinnitus) to assess aural fullness.

  4. Visual Analogue Scale (VAS) for tinnitus

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    The VAS will be used to assess the intensity of tinnitus. 0 indicates "no aural fullness", and 10 indicates "the most severe aural fullness".

  5. The Pittsburgh Sleep Quality Index (PSQI)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    The pittsburgh Sleep Qual-ityIndex (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. It has 19 questions which can be grouped into seven categories: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep dis-turbances, use of sleeping medication, and daytime dysfunction.The PSQI total score ranges from 0 to 21, with higher scores indicating worse sleep quality.

  6. The Zung Self-Rating Depression Scale(SDS)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    The Zung Self-Rating Depression Scale(SDS) will be adopted to assess depression.

  7. The Zung Self-Rating Anxiety Scale(SAS)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    The Zung Self-Rating Anxiety Scale(SAS) will be adopted to assess anxiety.

  8. World Health Organization Quality of Life-BREF questionnaire(WHOQOL-BREF)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    Quality of life assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF), yielding domain scores and an overall score (0-100; higher scores indicate better quality of life).

  9. Patient-Doctor Relationship Questionnaire (PDRQ-9)

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    Patient-Doctor Relationship Questionnaire (PDRQ-9) is to assess patient-doctor relationship.

  10. Adverse Events

    Time frame: Up to 4 weeks (manual acupuncture/sham acupuncture sessions 1-10)

    Adverse events assessed each acupuncture treatment visit using a acupuncture adverse events questionnaire recording presence and severity of side effects (e.g., subcutaneous hemorrhage, minor bleeding) related to acupuncture, plus event frequency.

  11. Assessment of blinding

    Time frame: At 12 weeks after randomization

    At the end of the study, we will determine the maintenance of blinding of patients by asking them whether they thought the needles had penetrated the skin.

  12. Acupuncture expectancy scale(AES)

    Time frame: Baseline visit, and end of treatment at 4 weeks after randomization,.

    The Acupuncture Expectancy Scale (AES) will be completed by participants in the verum and sham acupuncture groups at baseline and at the end of treatment (4 weeks after randomization). The questionnaire will not be administered to the usual care group.

  13. Massachusetts General Hospital Acupuncture Sensation Scale(MASS)

    Time frame: Up to 4 weeks (manual acupuncture/sham acupuncture sessions 1-10)

    The Massachusetts General Hospital Acupuncture Sensation Scale, which includes twelve specific descriptors-soreness, aching, deep pressure, heaviness, fullness or distension, tingling, numbness, sharp pain, dull pain, warmth, cold, and throbbing-as well as an open field for patients to describe the sensation in their own words, will be administered following a brief explanation of de qi sensations by the acupuncturist to participants in the verum acupuncture and sham acupuncture groups, while the usual care group will not receive this questionnaire.

  14. Auditory Sensitivity Scale

    Time frame: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

    Auditory Sensitivity Scale is a self-report questionnaire consisting of general questions on tinnitus and sound intolerance, along with 25 items rated on different scoring scales (e.g., 0/2/5, 0/1/2, 0/10), and provides a severity classification based on the total score: 31-55 for mild, 56-80 for moderate, 81-100 for severe, and 101-126 for very severe.

Other outcomes

  1. 10-item short version of the Big Five Inventory (BFI-10)

    Time frame: Baseline visit(before randomization)

    Personality is assessed by a10-item short version of the Big Five Inventory (BFI-10).

  2. Pure-Tone Audiometry(PTA)

    Time frame: Baseline visit(before randomization)

    Pure tone audiometry is conducted under standard soundproof conditions using the Hughson-Westlake method to obtain the air conduction threshold (bone conduction threshold is only used for diagnosis, to determine whether there is conductive hearing loss, and to assist in the screening process; statistical analysis only uses the air conduction threshold). The standard test frequencies range from 0.25 to 8 kHz. If conditions permit, extended high frequencies (Extended High Frequency, EHF; ≥ 9-16 kHz) are added, and necessary masking is performed in accordance with the norms.

Study contacts

Contact information is provided by the study sponsor or research team.

Dan Bing, PhD

CONTACT

[email protected]

86+13971058388

Dan Bing, PhD

CONTACT

[email protected]

86-13971058388

Sponsors and collaborators

Lead sponsor

Dan Bing

Other

Collaborators

  • Hubei Xinhua Hospital
  • Qianjiang Central Hospital
  • Taihe Hospital
  • The Third People's Hospital of Hubei Province
  • Wuhan No.1 Hospital

Registry information

Official study title

Manual Acupuncture Versus Sham Acupuncture and Usual Care for Acute Primary Tinnitus: Multicentre, Randomized Clinical Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 7, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.